Sagimet Biosciences (SGMT) Treasury Shares (2023 - 2026)

Sagimet Biosciences' Treasury Shares history runs 4 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 2.61% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 2.61% YoY), while the FY2025 annual figure was $830077.0, down 1.69% from the prior year.
• Treasury Shares was $1.1 million for Q1 2026 at Sagimet Biosciences, up from $830077.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.1 million in Q4 2023 to a low of $816937.0 in Q3 2025.
• Historically, Treasury Shares has averaged $1.0 million across 4 years, with a median of $1.1 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Treasury Shares decreased 25.43% in 2024, then advanced 2.61% in 2026.
• A 4-year view of Treasury Shares shows it stood at $1.1 million in 2023, then slipped by 25.43% to $844382.0 in 2024, then declined by 1.69% to $830077.0 in 2025, then soared by 35.78% to $1.1 million in 2026.
• The last three Treasury Shares figures came in at $1.1 million (Q1 2026), $830077.0 (Q4 2025), and $816937.0 (Q3 2025), per Business Quant data.